Acknowledgement to referees

    Dear Reader,

    As we reach the final issue of Pharmaceutical Medicine for 2019, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.

    2019 was a successful year for Pharmaceutical Medicine. Over 50 articles have been published; the most popular of these, in terms of downloads from SpringerLink, have been:

    Mockute R, Desai S, Perera S, et al. Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation. Pharm Med 2019;33(2):109–20.

    Barnes A & Patrick S. Lay Summaries of Clinical Study Results: An Overview. Pharm Med 2019;33(4):261–8.

    Lem J, Younus M, Aram JA, et al. Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey. Pharm Med 2019;33(2):121–33.

    Del Parigi A, Tang W, Liu D, et al. Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data. Pharm Med 2019;33(3):209–17.

    Zografos, L.J., Andrews, E., Wolin, D.L. et al. Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures. Pharm Med 2019;33(3):235–46.

    We thank the authors who have contributed articles to Pharmaceutical Medicine over the course of 2019. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Pharmaceutical Medicine in the last 12 months:

    Danielle Abatemarco, USA

    Danielle S. Abraham, USA

    Elaine Agyemang, UK

    Abdulrazaq S. Al-Jazairi, Saudi Arabia

    Rocio Aller-de la Fuente, Spain

    Lorna Bailey, UK

    Anjan Banerjee, UK

    Andrew Bate, UK

    Brijmohan S. Bhau, India

    Gene L. Bidwell III, USA

    Sheila M. Bird, UK

    Kevin V. Blake, UK

    François Bocquet, France

    Marc Boutin, USA

    Karen Bowker, UK

    Maria Brotons, Spain

    Luis Calzadilla‐Bertot, Australia

    Daniel P. Carpenter, USA

    Alison R. Carter, UK

    Angelika Chroni, Greece

    Arrigo F. G. Cicero, Italy

    Shaun Comfort, USA

    Jonathan J. Darrow, USA

    Hugo J. de Boer, Norway

    Eric Deconinck, Belgium

    Murray P. Ducharme, Canada

    D. Epstein, Spain

    Jérôme Fayette, France

    Robert J. Fontana, USA

    Tim Friede, Germany

    Joseph H. Friedman, USA

    Giovanni Gabutti, Italy

    Afschin Gandjour, Germany

    Alberto Grignolo, USA

    Christophe Guignabert, France

    Shahrukh K. Hashmi, USA

    M. E. B. Holbein, USA

    Claudia Jacova, USA

    Rosanne Janssens, Belgium

    Mary J. Kallman, USA

    Seung H. Kang, Republic of Korea

    Sigal Kaplan, Israel

    Ronald Kiguba, Uganda

    Craig Klugman, USA

    Bartha M. Knoppers, Canada

    Andrew J. Krentz, USA

    Ryosuke Kuribayashi, Japan

    Michael Levy, USA

    James H. Lewis, USA

    Frank R. Lichtenberg, USA

    Yoon K. Loke, UK

    K. Louati, Tunisia

    Mathias Møllebæk, Denmark

    Jorge P. Machado, Portugal

    Terri Madison, USA

    Hiroshi Matsuda, Japan

    Cyrus R. Mehta, USA

    Marsha Michie, USA

    Jennifer E. Miller, USA

    David Montani, France

    Thomas J. Moore, USA

    Kareem A. Mosa, United Arab Emirates

    Monica A. Munoz, USA

    Rahul H. Nagadia, Singapore

    Mamoru Narukawa, Japan

    Niclas Nilsson, Denmark

    Jordi Ocaña, Spain

    Antoine Pariente, France

    Maria K. Parr, Germany

    Pedro Plans-Rubió, Spain

    Henrike Potthast, Germany

    Sandra Prior, UK

    David K. Raynor, UK

    Alan Remaley, USA

    Jonathan C. P. Roos, UK

    Christian H. Ross, USA

    Shruthi Shanmukha, USA

    Amir Shlomai, Israel

    Michael Sinha, USA

    Jim Slattery, UK

    Nicholas P. Tatonetti, USA

    Kednapa Thavorn, Canada

    Laszlo Tothfalusi, Hungary

    Lill Trogstad, Norway

    Olga Tsave, Greece

    Carolina Ung, Macao

    R. Martijn van der Plas, The Netherlands

    Katarina Vucic, Croatia

    Jonathan H. Watanabe, USA

    Lesley Wise, UK

    Janet Wittes, USA

    Michael Wonder, Australia

    Guy Yeoman, UK

    In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

    Dr Peter R. Arlett, MD MRCP. European Medicines Agency, London, England

    Dr John F. Beary III, MD FACP. University of Cincinnati, Cincinnati, OH, USA

    Dr Sander Becker, MD. Consultants in Pharmaceutical Medicine, Rose Bay North, NSW, Australia

    Dr Ambrogio Bottoni, MD. Pfizer Inc., Milan, Italy

    Dr Torbjӧrn Callréus, MD PhD. University of Copenhagen, Copenhagen, Denmark

    Dr Norbert Clemens, MD PhD CPI. Association of Clinical Research Professionals Board of Trustees, Heidelberg, Germany

    Mr Francis P. Crawley, PhL. Good Clinical Practice Alliance – Europe, Brussels, Belgium

    Dr Jean-Paul Deslypere, MD PhD. Council on Education in Pharmaceutical Medicine, Singapore

    Dr Francesco De Tomasi, MD. Scientific Society for Applied Research, Milan, Italy

    Professor Stephen J.W. Evans, BA MSc FRCP FISPE Hon. FRCP. London School of Hygiene and Tropical Medicine, London, England

    Dr Georg Ferber, PhD. Statistik Georg Ferber GmbH, Riehen, Switzerland

    Professor Anthony W. Fox, MSc MBBS MD FFPM FRCP DipPharmMed MCSFS DipFHI MFMLM CBiol. King’s College London, London, England

    Professor Sanjay K. Garg, PhD. University of South Australia, Adelaide, SA, Australia

    Dr E. Stewart Geary, MD. Eisai Co. Ltd., Tokyo, Japan

    Mr Kenneth A. Getz, MBA. Tufts University Medical School, Boston, MA, USA

    Mr Ari Gnanasakthy, BSc MSc MBA. RTI Health Solutions, Research Triangle Park, NC, USA

    Dr Ulrich Granzer, PhD. Granzer Regulatory Consulting & Services, Munich, Germany

    Professor Jan D. Hirsch, BSPharm PhD. University of California, Irvine, CA, USA

    Mr Alan Hunter, LLB BPharm. Independent Pharmaco-Legal Adviser, Staines, England

    Dr Shaun Kilminster, BSc(Hon) PGCEd MSc(Psych) CPsychol PhD FSS Hon FFPM. Institute of Naval Medicine, Alverstoke, England

    Dr Ambrose O. Isah, MD. University of Benin, Benin, Nigeria, Africa

    Dr Greg Koski, MD PhD CPI. Alliance for Clinical Research Excellence and Safety, Cambridge, MA, USA

    Dr Marlene Llopíz Avíles, BA MD MPH. Association of Medical Specialists in the Pharmaceutical Industry, Mexico City, Mexico

    Dr Marcelo Marotti, MD PhD. AstraZeneca UK Ltd., Macclesfield, England

    Dr Peter G. M. Mol, PhD, PharmD. Dutch Medicines Evaluation Board, Utrecht, the Netherlands

    Dr Shunsuke Ono, PhD. University of Tokyo, Tokyo, Japan

    Professor Sir Michael Rawlins, BSc MD FRCP FFPM. Medicines and Healthcare Products Regulatory Agency, London, England

    Dr Klaus Rose, MD MS. Klausrose Consulting, Riehen, Switzerland

    Professor Sam Salek, BPharm PhD RPh MRPSGB FFPM FESCP. University of Hertfordshire, Hatfield, England

    Professor Grannum R. Sant, MD FRCS FACS. Tufts University School of Medicine, Boston, MA, USA

    Dr Ruth Savage, MB BS MSc. University of Otago, Dunedin, New Zealand

    Dr Johanna A. Schenk, MD FFPM DipPharmMed DGPharMed. PPH plus GmbH & Co. KG, Frankfurt/Main, Germany

    Dr Jeffrey W. Sherman, MD FACP. Horizon Pharma, Deerfield, IL, USA

    Dr Honorio Silva, MD. International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine, New York, NY, USA

    Dr Robert N. Smith, BSc MD FRCP FFPM. St Ippolytis, Hitchin, England

    Dr Noel Snell, FRCP FFPM FRIPH FIBiol. National Heart & Lung Institute, London, England

    Dr Almath Spooner, PhD. Health Products Regulatory Agency, Dublin, Ireland

    Professor Peter D. Stonier, BA BSc PhD MB ChB MRCPsych FRCP FRCPE FFPM. King’s College London, London, England

    Dr Robert Temple, MD. Center for Drug Evaluation & Research, Food and Drug Administration, Rockville, MD, USA

    Professor Rolf Teschke, MD. Klinikum Hanau, Hanau, Germany

    Professor Stuart R. Walker, BSc PhD CChem CBiol FRSC FIBiol FInstD FRCPath. Centre for Innovation in Regulatory Science, Carshalton, England

    We do hope that you have found the articles published throughout the year in Pharmaceutical Medicine to be interesting and informative. The editorial schedule for 2020 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

    With best wishes,

    Sue Pochon

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Acknowledgement to referees. Pharm Med 33, 441–444 (2019). https://doi.org/10.1007/s40290-019-00310-2

    Download citation